Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dermatological Medicine
Volume 2011 (2011), Article ID 412684, 3 pages
http://dx.doi.org/10.1155/2011/412684
Case Report

Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application

1Department of Dermatology, Cleveland Clinic, Cleveland, OH 44195, USA
2Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA

Received 19 July 2011; Accepted 25 August 2011

Academic Editors: E. Erkek, M. Hide, and G. E. Piérard

Copyright © 2011 Natasha Atanaskova Mesinkovska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. Sauder, “Immunomodulatory and pharmacologic properties of imiquimod,” Journal of the American Academy of Dermatology, vol. 43, no. 1, pp. S6–S11, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. Aldara [package insert], Graceway Pharmaceuticals LLC, Bristol, Tenn, USA, 2009.
  3. W. E. Love, J. D. Bernhard, and J. S. Bordeaux, “Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review,” Archives of Dermatology, vol. 145, no. 12, pp. 1431–1438, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. Zyclara [package insert], Graceway Pharmaceuticals LLC, Bristol, Tenn, USA, 2009.
  5. J. Kulp, S. Levy, M. C. Fein, M. Adams, J. Furst, and T. C. Meng, “Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and/or balding scalp,” Archives of Dermatological Research, vol. 302, no. 7, pp. 539–544, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. Klein, M. Landthaler, and S. Karrer, “Pityriasis rubra pilaris: a review of diagnosis and treatment,” American Journal of Clinical Dermatology, vol. 11, no. 3, pp. 157–170, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C. M. Magro and A. N. Crowson, “The clinical and histomorphological features of pityriasis rubra pilaris. A comparative analysis with psoriasis,” Journal of Cutaneous Pathology, vol. 24, no. 7, pp. 416–424, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bauza, L. J. Del Pozo, C. Saus, and A. Martin, “Pemphigus-like lesions induced by imiquimod,” Clinical and Experimental Dermatology, vol. 34, no. 5, pp. e60–e62, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. Campagne, M. Roca, and A. Martínez, “Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 109, no. 2, pp. 224–227, 2003. View at Publisher · View at Google Scholar
  10. R. Lin, D. J. Ladd, D. J. Powell, and B. V. Way, “Localized pemphigus foliaceus induced by topical imiquimod treatment,” Archives of Dermatology, vol. 140, no. 7, pp. 889–890, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. Mashiah, S. Brenner, D. J. Ladd, and R. J. Lin, “Possible mechanisms in the induction of pemphigus foliaceus by topical imiquimod treatment,” Archives of Dermatology, vol. 141, no. 7, pp. 908–909, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. F. C. Yang, C. Jessup, M. Dahiya, and R. Reynolds, “Pityriasis rubra pilaris exacerbation with topical use of imiquimod,” International Journal of Dermatology, vol. 47, no. 10, pp. 1076–1078, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. E. Gómez-Moyano, A. Crespo-Erchiga, A. Vera Casaño, and A. Sanz Trelles, “Pityriasis rubra pilaris with focal acantholytic dyskeratosis during treatment with imiquimod 5% cream,” Actas Dermo-Sifiliograficas, vol. 101, no. 10, pp. 898–900, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. Schön and M. Schön, “TLR7 and TLR8 as targets in cancer therapy,” Oncogene, vol. 27, no. 2, pp. 190–199, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. L. Van Der Fits, S. Mourits, J. S. A. Voerman et al., “Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis,” Journal of Immunology, vol. 182, no. 9, pp. 5836–5845, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus